Dr. Dianne Soukfun Cheung, MD

Dr. Cheung practices at Madison Park Surgery & Laser Center in Torrance, California.

Dr. Cheung's NPI, 1417197062, was assigned on February 23, 2009. Dr. Cheung graduated from UC San Diego School of Medicine in 2004. Dr. Cheung holds California license A93092.

Dr. Cheung's primary practice is Madison Park Surgery & Laser Center, at 3445 Pacific Coast Hwy, Torrance, CA 90505 in Los Angeles County. The practice phone is (310) 530-2900.

Dr. Cheung's primary practice is Madison Park Surgery & Laser Center in Torrance, California. Dr. Cheung is also affiliated with Torrance Memorial Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Cheung to 2 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheung practices, 6 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Cheung's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Cheung is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dr. Cheung is licensed in California.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, fluid and electrolyte imbalances, high cholesterol, hypercalcemia, osteoporosis and overactive thyroid among the conditions Dr. Cheung treats.

CMS data shows 13,218 Medicare services from Dr. Cheung across 14 procedure codes in 2024, for 686 Medicare patients. Medicare paid $395,729 for them. Every service was in an office.

CMS counts 686 Medicare patients who saw Dr. Cheung in 2024. The largest group is 65 to 74, with 322 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cheung's median patient age at 65, with 77% women.

In 2024, Dr. Cheung wrote 4,100 Medicare Part D claims for 552 patients. 52% of them were for generic drugs. CMS names the drug for 3,801 of them, across 51 drugs with 11 or more claims each, at $1,442,640 in total drug cost. In 2023, CMS named 3,790 claims across 49 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Cheung for performance year 2024, reported as part of a group. Dr. Cheung accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cheung as offering telehealth.

Dmand AI links 2 papers to Dr. Cheung, published from 2009 to 2016. Dr. Cheung's most frequent co-authors are Matthew Lin Hung, MD and James Wu, MD.

CMS Open Payments shows 71 general payments to Dr. Cheung from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 49% of the total. Eli Lilly and Company paid the most, $2,166. It also lists 9 research payments totaling $4,899 from 2024 to 2025, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Cheung, most recently CMS Stage 1 EHR in 2013.

Dr. Cheung graduated from UC San Diego School of Medicine in 2004. Dr. Cheung is a member of AACE and ENDO.

Dr. Cheung is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.